Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer - Ding, Qingqing; Huo, Longfei; Yang, Jer-Yen; Xia, Weiya; Wei, Yongkun; Liao, Yong; Chang, Chun-Ju; Yang, Yan; Lai, Chien-Chen; Lee, Dung-Fang; Yen, Chia-Jui; Chen, Yun-Ju Rita; et al. (Cancer research (Chicago, Ill.), 2008)
Keywords: Antineoplastic Agents - pharmacology; Benzenesulfonates - pharmacology; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cell Line, Tumor; Down-Regulation; Humans; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide - analogs & derivatives; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase - metabolism; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 - physiology; Pyridines - pharmacology; Sorafenib